Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price shot up 2.6% on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.15 ($0.04). 555,891 shares traded hands during mid-day trading, an increase of 247% from the average session volume of 160,411 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The stock has a market capitalization of £9.65 million, a price-to-earnings ratio of -327.00 and a beta of 0.07. The business’s 50 day simple moving average is GBX 2.72 and its 200-day simple moving average is GBX 3.15.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Stock Sentiment Analysis: How it Works
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- 3 REITs to Buy and Hold for the Long Term
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
